SHL to showcase innovative solutions for high volume drug delivery at Pharmapack Europe
SHL Group is looking forward to exhibiting at the 2019 Pharmapack, Europe’s dedicated pharmaceutical packaging and drug delivery event from February 6-7 in Paris, France.
At the center of this year’s exhibition is Molly® 2.25, SHL’s high volume variation of its classic Molly® autoinjector, designed with a preconfigured technology to help pharmaceutical companies minimize initial equipment investments and speed up development timelines. Boasting an intuitive design that meets a variety of patient handling profiles, Molly® 2.25 supports the trend for injection volumes in the 1-2.25mL range to meet the increasing need for the simple delivery of larger doses. SHL is also looking forward the market introduction of the first drug product based on the Molly® 2.25 program.
Another highlight at this year’s event is the range of autoinjectors built with SHL’s Needle Isolation Technology (NIT®). This proprietary technology allows cartridge-based injection devices to be built as easy-to-use autoinjectors with permanently hidden needles. “The NIT® is a true problem solver because cartridges not only open up a world of opportunities for pharma companies, it also offers patients a safe and intuitive experience without sacrificing usability,” said Magnus Fastmarken, SHL’s global director of marketing.
This year, SHL is again pairing up with Innovation Zed to present InsulCheck at Pharmapack’s Innovation Gallery. This year’s display, InsulCheck Connect, is a smart pen injector add-on that displays the time elapsed since last injection. It can be connected to 3rd party service applications to track insulin injection. InsulCheck Connect is compatible with a *variety of existing insulin injection pens on the market and can be customized to support other pen injector projects.
Visitors are invited to explore SHL’s innovative injectable drug delivery solutions at Stand B44 at the Paris Expo Porte de Versailles.
*For full list of pen injectors compatible with InsulCheck Connect, please refer to the company website, or contact us at firstname.lastname@example.org.)